We are live on
!
Find out more
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
147 hedge funds and large institutions have $202M invested in Synergy Pharmaceuticals, Inc Common Stock in 2018 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 39 increasing their positions, 44 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
4% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 27
1% less funds holding
Funds holding: 149 → 147 (-2)
11% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 44
31% less capital invested
Capital invested by funds: $291M → $202M (-$89.5M)
42% less call options, than puts
Call options by funds: $4.26M | Put options by funds: $7.36M
Holders
147
Holders Change
-2
Holders Change %
-1.34%
% of All Funds
3.37%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
39
Reduced
44
Closed
27
Calls
$4.26M
Puts
$7.36M
Net Calls
-$3.1M
Net Calls Change
+$1.1M
Top Buyers
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$9.67M |
| 2 |
Barclays
London,
United Kingdom
|
+$1.16M |
| 3 |
Millennium Management
New York
|
+$1.03M |
| 4 |
Morgan Stanley
New York
|
+$746K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$739K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$26.2M |
| 2 |
PC
Paulson & Co
New York
|
-$8.92M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$6.93M |
| 4 |
Citigroup
New York
|
-$3.45M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.11M |
